Argent Biopharma Ltd has released a press release.
Argent Signs NLC Licence to Expand Antiviral Portfolio
Earlier from Argent Biopharma
- Appendix 4E and 2026 Annual Report
- FDA-CVM Establish INAD File for CannEpil Veterinary Program
- US Veterinary Development Programme for CannEpil Commences
- CannEpil Global Licence Expands into Veterinary Healthcare